Using biomarkers to define disease risk in pre-clinical Alzheimer’s disease
Lefkos Middleton Imperial College London, UK
Auditorium iCBR/IBILI, FMUC-polo 3
Host: João Malva and Ana Cristina Rego
Funded by ERDF - European Regional Development Fund through COMPETE 2020 and National Funds via FCT - Fundação para a Ciência e Tecnologia, under projects POCI-01-0145-FEDER-007440 e UIDB/04539/2020.

© 2020 CNC - Center for Neuroscience and Cell Biology
powered by DigitalWind